rs2943521

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002458.3(MUC5B):​c.11725G>A​(p.Val3909Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.445 in 1,609,662 control chromosomes in the GnomAD database, including 163,161 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V3909A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.43 ( 14462 hom., cov: 28)
Exomes 𝑓: 0.45 ( 148699 hom. )

Consequence

MUC5B
NM_002458.3 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -5.04

Publications

16 publications found
Variant links:
Genes affected
MUC5B (HGNC:7516): (mucin 5B, oligomeric mucus/gel-forming) This gene encodes a member of the mucin family of proteins, which are highly glycosylated macromolecular components of mucus secretions. This family member is the major gel-forming mucin in mucus. It is a major contributor to the lubricating and viscoelastic properties of whole saliva, normal lung mucus and cervical mucus. This gene has been found to be up-regulated in some human diseases, including sinus mucosa of chronic rhinosinusitis (CRS), CRS with nasal polyposis, chronic obstructive pulmonary disease (COPD) and H. pylori-associated gastric disease, and it may be involved in the pathogenesis of these diseases. [provided by RefSeq, Jul 2010]
MUC5B-AS1 (HGNC:53936): (MUC5B antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=6.6728385E-6).
BP6
Variant 11-1248605-G-A is Benign according to our data. Variant chr11-1248605-G-A is described in ClinVar as Benign. ClinVar VariationId is 403171.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.639 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MUC5BNM_002458.3 linkc.11725G>A p.Val3909Ile missense_variant Exon 31 of 49 ENST00000529681.5 NP_002449.2 Q9HC84
MUC5B-AS1NR_157183.1 linkn.56+1016C>T intron_variant Intron 1 of 1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MUC5BENST00000529681.5 linkc.11725G>A p.Val3909Ile missense_variant Exon 31 of 49 5 NM_002458.3 ENSP00000436812.1 Q9HC84
MUC5B-AS1ENST00000532061.2 linkn.56+1016C>T intron_variant Intron 1 of 1 5

Frequencies

GnomAD3 genomes
AF:
0.431
AC:
64766
AN:
150336
Hom.:
14445
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.329
Gnomad AMI
AF:
0.537
Gnomad AMR
AF:
0.536
Gnomad ASJ
AF:
0.433
Gnomad EAS
AF:
0.657
Gnomad SAS
AF:
0.433
Gnomad FIN
AF:
0.507
Gnomad MID
AF:
0.405
Gnomad NFE
AF:
0.437
Gnomad OTH
AF:
0.443
GnomAD2 exomes
AF:
0.469
AC:
113204
AN:
241520
AF XY:
0.462
show subpopulations
Gnomad AFR exome
AF:
0.302
Gnomad AMR exome
AF:
0.590
Gnomad ASJ exome
AF:
0.422
Gnomad EAS exome
AF:
0.660
Gnomad FIN exome
AF:
0.491
Gnomad NFE exome
AF:
0.437
Gnomad OTH exome
AF:
0.459
GnomAD4 exome
AF:
0.446
AC:
651299
AN:
1459208
Hom.:
148699
Cov.:
139
AF XY:
0.445
AC XY:
323023
AN XY:
725890
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.318
AC:
10507
AN:
33074
American (AMR)
AF:
0.581
AC:
25889
AN:
44544
Ashkenazi Jewish (ASJ)
AF:
0.421
AC:
10987
AN:
26112
East Asian (EAS)
AF:
0.705
AC:
27957
AN:
39650
South Asian (SAS)
AF:
0.425
AC:
36639
AN:
86170
European-Finnish (FIN)
AF:
0.490
AC:
26098
AN:
53240
Middle Eastern (MID)
AF:
0.432
AC:
2390
AN:
5536
European-Non Finnish (NFE)
AF:
0.436
AC:
484209
AN:
1110652
Other (OTH)
AF:
0.442
AC:
26623
AN:
60230
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.387
Heterozygous variant carriers
0
19523
39047
58570
78094
97617
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14754
29508
44262
59016
73770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.431
AC:
64807
AN:
150454
Hom.:
14462
Cov.:
28
AF XY:
0.438
AC XY:
32203
AN XY:
73478
show subpopulations
African (AFR)
AF:
0.329
AC:
13393
AN:
40690
American (AMR)
AF:
0.537
AC:
8121
AN:
15136
Ashkenazi Jewish (ASJ)
AF:
0.433
AC:
1500
AN:
3462
East Asian (EAS)
AF:
0.658
AC:
3327
AN:
5058
South Asian (SAS)
AF:
0.433
AC:
2044
AN:
4724
European-Finnish (FIN)
AF:
0.507
AC:
5297
AN:
10454
Middle Eastern (MID)
AF:
0.391
AC:
115
AN:
294
European-Non Finnish (NFE)
AF:
0.437
AC:
29593
AN:
67658
Other (OTH)
AF:
0.449
AC:
929
AN:
2070
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
1603
3206
4809
6412
8015
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
594
1188
1782
2376
2970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.430
Hom.:
2421
Bravo
AF:
0.431
ExAC
AF:
0.454
AC:
54754

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 09, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.054
BayesDel_addAF
Benign
-0.87
T
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.17
DANN
Benign
0.75
DEOGEN2
Benign
0.015
T
Eigen
Benign
-2.1
Eigen_PC
Benign
-2.1
FATHMM_MKL
Benign
0.0021
N
LIST_S2
Benign
0.38
T
MetaRNN
Benign
0.0000067
T
MetaSVM
Benign
-0.87
T
MutationAssessor
Benign
-1.6
N
PhyloP100
-5.0
PrimateAI
Benign
0.22
T
PROVEAN
Benign
0.020
N
REVEL
Benign
0.065
Sift
Benign
1.0
T
Vest4
0.041
ClinPred
0.0074
T
GERP RS
-6.2
Varity_R
0.019
gMVP
0.13
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2943521; hg19: chr11-1269835; COSMIC: COSV71589897; API